Integer (NYSE:ITGR) Announces Quarterly Earnings Results

Integer (NYSE:ITGR) issued its quarterly earnings data on Thursday. The medical equipment provider reported $1.79 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.68 by $0.11, Zacks reports. Integer had a net margin of 4.75% and a return on equity of 12.84%. The company had revenue of $467.69 million for the quarter, compared to the consensus estimate of $466.45 million. During the same period last year, the firm posted $1.43 EPS. Integer’s revenue for the quarter was up 8.4% on a year-over-year basis. Integer updated its FY 2025 guidance to 6.290-6.430 EPS.

Integer Price Performance

Shares of ITGR stock opened at $72.94 on Friday. The company has a market capitalization of $2.56 billion, a PE ratio of 30.52, a price-to-earnings-growth ratio of 0.58 and a beta of 0.97. The firm has a fifty day simple moving average of $103.61 and a 200-day simple moving average of $112.44. The company has a current ratio of 3.71, a quick ratio of 2.18 and a debt-to-equity ratio of 0.70. Integer has a twelve month low of $66.50 and a twelve month high of $146.36.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the stock. Wells Fargo & Company restated an “equal weight” rating and issued a $80.00 target price (down previously from $132.00) on shares of Integer in a research note on Friday. Benchmark reissued a “hold” rating on shares of Integer in a research note on Friday. Raymond James Financial reaffirmed an “outperform” rating and set a $95.00 price target (down previously from $143.00) on shares of Integer in a research report on Friday. Truist Financial dropped their price target on shares of Integer from $121.00 to $88.00 and set a “buy” rating for the company in a research report on Friday. Finally, Citigroup downgraded shares of Integer from a “buy” rating to a “neutral” rating and decreased their price objective for the stock from $140.00 to $77.00 in a research note on Thursday. Four analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $97.75.

Institutional Trading of Integer

Institutional investors have recently added to or reduced their stakes in the stock. EverSource Wealth Advisors LLC raised its holdings in shares of Integer by 210.5% during the second quarter. EverSource Wealth Advisors LLC now owns 534 shares of the medical equipment provider’s stock worth $66,000 after purchasing an additional 362 shares during the period. Northwestern Mutual Wealth Management Co. grew its position in Integer by 861.1% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 692 shares of the medical equipment provider’s stock valued at $85,000 after buying an additional 620 shares in the last quarter. Vident Advisory LLC bought a new position in Integer in the 2nd quarter valued at about $218,000. Jump Financial LLC bought a new position in shares of Integer during the 2nd quarter valued at about $222,000. Finally, State of Wyoming bought a new position in shares of Integer during the 2nd quarter valued at about $233,000. 99.29% of the stock is owned by institutional investors and hedge funds.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.